Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,640,132
-$17,331,018 QoQ
Shares Held
275,753
-70.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#521
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSSIAM holds $190,268,884 across 10 Drug Manufacturers - General names. PFE ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,300 | $108,308,538 | |
| 2 | AZN |
Astrazeneca PLC
|
80,256 | $15,218,142 | |
| 3 | AMGN |
Amgen Inc
|
36,294 | $13,142,783 | |
| 4 | ABBV |
AbbVie Inc.
|
50,502 | $12,708,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
91,787 | $11,794,629 | |
| 6 | BIIB |
Biogen Inc.
|
39,223 | $8,474,521 | |
| 7 | PFE |
Pfizer Inc
This page
|
275,753 | $6,640,132 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
49,573 | $6,263,052 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,640,132 | 275,753 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $23,971,150 | 940,783 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $136,969,889 | 5,650,573 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $83,660,390 | 3,301,515 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,048,888 | 265,695 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,330,719 | 184,199 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,425,853 | 193,919 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,012,843 | 180,643 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,416,213 | 153,394 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $12,610,205 | 380,169 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,841,899 | 540,946 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,278,483 | 202,904 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $31,664,782 | 617,970 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,595,200 | 150,713 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,826,393 | 72,981 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $37,550,851 | 725,340 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,910,963 | 354,123 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,488,624 | 313,616 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,587,953 | 295,913 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,910,050 | 107,923 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $109,215 | 2,967 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $22,473,920 | 612,369 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,980,737 | 213,478 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,256,651 | 99,775 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||